Inavisis, Inc. Launches Licensing Program for Rocket Gene, LLC Technology Relating to Enhancing the Infective of Retroviruses
A full licensing campaign has been developed to provide exclusive and non-exclusive license agreements on fair, reasonable and non-discriminatory terms in the human, animal and plant market applications for the ) "Method for Enhancing Infectivity of Retroviruses".
- (1888PressRelease) May 10, 2012 - San Diego, CA - Inavisis, Inc. announced today that they are launching a premier licensing program for filed patent (PCT/US2010/001461) "Method for Enhancing Infectivity of Retroviruses".
Rocket Gene, LLC has developed a method for enhancing the transductive efficiency of lentiviruses up to eight fold in primate and non-primate mammalian cells. This technology alters viruses directly and stably. This allows enhanced viruses to be stored for later use without loss of efficacy. A particularly appealing aspect of this technology is that no agents are added to target cells. The absence of added agents lessens the risk of introduced artifacts in the context of basic research, and simplifies the enhancement of lentiviral transductive efficiency in the clinic setting for applications such as gene therapy.
Sam Khoury, PHD, MBA, president of Inavisis, Inc. and a leading expert with over 25 years of technology monetization mentioned "The broad claims of this new patent will provide the market place with a platform technology that will have major impact on gene therapy for cancer treatment, fight viral infection and replace gene function to correct genetic defect in human, animal and plant cells".
Rocket Gene, LLC stated that "We are excited that this technology will be offered to companies that make tools for Basic Research kits, Therapeutic and Diagnostic fields. This technology will be useful not only to large-scale manufacturers wishing to consistently produce high-titer virus, specialized cell lines, and specific gene products on a large scale, but also to individual research scientists who need products that save time and let them focus on what's really important: the science".
About Rocket Gene, LLC
Rocket Gene, LLC, headquartered in Solana Beach, California is a holding company that specializes in gene delivery technology. Their mission is to make those technologies available to companies that work in Basic Research, Therapy and Diagnostics on a business friendly basis. Rocket Gene, LLC was established in 2011.
About Inavisis, Inc.
Inavisis, Inc., headquartered in San Diego, California is a leading intellectual property corporation that creates strategic licensing campaigns based on a focused technology leveraging strategy that has been perfected over the past 25 years. INAVISIS® was established in January 2000 and became a premier intellectual property boutique specializing in valuation, licensing and enforcement of intellectual properties generating millions of dollars from leveraging the patent portfolios of fortune 500 companies. For more information please visit www.inavisis.com.
Contact:
Sam Khoury, PHD, MBA
Inavisis, Inc.
858.794.1555
skhoury ( @ ) inavisis dot com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam